PT - JOURNAL ARTICLE AU - Teo, Kevin AU - Abeysekera, Kushala W. M. AU - Adams, Leon AU - Aigner, Elmar AU - Banerjee, Rajarshi AU - Basu, Priyadarshi AU - Berg, Thomas AU - Bhatnagar, Pallav AU - Buch, Stephan AU - Canbay, Ali AU - Caprio, Sonia AU - Chatterjee, Ankita AU - Chen, Yii-Der Ida AU - Chowdhury, Abhijit AU - Datz, Christian AU - de Gracia Hahn, Dana AU - DiStefano, Johanna K. AU - Dong, Jiawen AU - Duret, Amedine AU - , AU - Emdin, Connor AU - Fairey, Madison AU - Gerhard, Glenn S AU - , AU - Guo, Xiuqing AU - Hampe, Jochen AU - Hickman, Matthew AU - Heintz, Lena AU - Hudert, Christian AU - Hunter, Harriet AU - Kelly, Matt AU - Kozlitina, Julia AU - Krawczyk, Marcin AU - Lammert, Frank AU - Langenberg, Claudia AU - Lavine, Joel AU - Li, Lin AU - Lim, Hong Kai AU - Luukkonen, Panu AU - Melton, Phillip E. AU - Mori, Trevor A. AU - Parisinos, Constantinos A. AU - Pillai, Sreekumar G AU - Qayyum, Faiza AU - Reichert, Matthias C. AU - Romeo, Stefano AU - Rotter, Jerome AU - Im, Yu Ri AU - Santoro, Nicola AU - Schafmayer, Clemens AU - Speliotes, Elizabeth K. AU - Stender, Stefan AU - Stickel, Felix AU - Still, Christopher D. AU - Strnad, Pavel AU - Taylor, Kent D. AU - Tybjærg-Hansen, Anne AU - Umano, Giuseppina Rosaria AU - Utukuri, Mrudula AU - Valenti, Luca AU - Wareham, Nicholas J. AU - Wattacheril, Julia AU - Yki-Järvinen, Hannele AU - Mann, Jake P. TI - rs641738C&gt;T near <em>MBOAT7</em> promotes steatosis, NASH, fibrosis and hepatocellular carcinoma in non-alcoholic fatty liver disease: a meta-analysis AID - 10.1101/19013623 DP - 2020 Jan 01 TA - medRxiv PG - 19013623 4099 - http://medrxiv.org/content/early/2020/01/13/19013623.short 4100 - http://medrxiv.org/content/early/2020/01/13/19013623.full AB - A common genetic variant near MBOAT7 (rs641738C&gt;T) has been previously associated with hepatic fat and advanced histology in non-alcoholic fatty liver disease (NAFLD), however, these findings have not been consistently replicated in the literature. Therefore, we aimed to establish whether rs641738 is a risk factor for NAFLD through meta-analysis. Data from 134,015 participants (7,692 with liver biopsies and 50,680 with imaging) was included in the meta-analysis. The minor T-allele of rs641738C&gt;T was associated with higher liver fat on CT/MRI using an additive genetic model (+0.05 standard deviations [95% CI: 0.01 – 0.09], p=0.025), and with an increased risk of NAFLD (per-allele OR: 1.08 [95% CI: 1.01 - 1.15]), nonalcoholic steatohepatitis (OR: 1.11 [95% CI: 1.02 - 1.21]), advanced fibrosis (OR: 1.14 [95% CI: 1.05 - 1.23]), and hepatocellular carcinoma (OR: 1.43 [95% CI: 1.22 - 1.67]) in adults with NAFLD. Sub-group analysis did not demonstrate a difference in Caucasians and non-Caucasians. Rs641738C&gt;T was not associated with markers of insulin resistance but was associated with higher risk of stroke in the UK Biobank. These data validate rs641738C&gt;T near MBOAT7 as a risk factor for the development, activity, and stage of NAFLD including hepatocellular carcinoma.Competing Interest StatementConnor Emdin reports personal fees from Navitor Pharma and Novartis.Clinical Protocols http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42018105507 Funding StatementJPM is supported by a Wellcome Trust Fellowship (216329/Z/19/Z) and a Children’s Liver Disease Foundation grant. NIH grants: R01HD028016 (SC), R01DK111038 (SC), R01DK114504 (NS), DK091601 (JKD), UL1TR001105 (JK). This study was supported by the German Federal Ministry for Education and Research (BmBF) through the Livers Systems Medicine (LiSyM) project. This work was supported by grants from the Swiss National Funds (SNF no. 310030_169196) and the Swiss Foundation for Alcohol Research (SSA) to FS. This Raine Study was supported by the National Health and Medical Research Council of Australia [grant numbers 403981, 353514 and 572613]. LV was supported by MyFirst Grant AIRC n.16888, Ricerca Finalizzata Ministero della Salute RF-2016-02364358, Ricerca corrente Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico, LV and AG. received funding from the European Union (EU) Programme Horizon 2020 (under grant agreement No. 777377) for the project LITMUS-“Liver Investigation: Testing Marker Utility in Steatohepatitis”. KWMA &amp; MH are supported by grants from MRC and Alcohol Research UK (MR/L022206/1). German Federal Ministry of Education and Research (BMBF LiSyM 031L0051 to F.L.) PL is supported by grants from the Sigrid Jusélius Foundation and the Novo Nordisk Foundation. The Fenland study was funded by grants to the MRC Epidemiology Unit (MC UU12015/1, MC UU 12015/5). RB and MK are employees of and shareholders in Perspectum Diagnostics Ltd. CAP is funded by a Wellcome Trust Clinical PhD Programme (206274/Z/17/Z).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSummary statistics available upon request.NAFLDnon-alcoholic fatty liver diseaseNAFLnon-alcoholic fatty liverNASHnon-alcoholic steatohepatitisHDLhigh-density lipoproteinHOMA-IRhomeostatic model assessment of insulin resistanceBMIbody mass indexALTalanine aminotransferaseCIconfidence intervalGGTgamma-glutamyl transferaseORodds ratioPNPLA3patatin-like phospholipase domain containing protein 3TM6SF2transmembrane 6 superfamily member 2TMC4transmembrane channel-like 4MBOAT7membrane bound O-acyltransferase domain containing 7